•
Dec 30, 2024

Nuvation Bio Q4 2024 Earnings Report

Expected Revenue:$0
Expected EPS:-$0.14
40.0% YoY
Total Revenue
$5.71M
0
Gross Profit
$1.28M
Previous year: -$55K
-2420.0%
Cash and Equivalents
$503M
Previous year: $42.6M
+1078.7%
Free Cash Flow
-$46.3M
Previous year: -$15M
+207.7%
Total Assets
$541M
Previous year: $621M
-13.0%

Nuvation Bio

Nuvation Bio